Huong T. Le-Petross, M.D., F.R.C.P.C., F.B.S.I.

Peer-Reviewed Articles

1. Xu Z, Zhou Z, Son JB, Feng H, Adrada BE, Moseley TW, Candelaria RP, Guirguis MS, Patel MM, Whitman GJ, Leung JWT, Le-Petross HTC, Mohamed RM, Panthi B, Lane DL, Chen H, Wei P, Tripathy D, Litton JK, Valero V, Huo L, Hunt KK, Korkut A, Thompson A, Wang Y, Yam C, Rauch GML, Ma J. Deep learning models based on pretreatment MRI and clinicopathological data to predict responses to neoadjuvant systemic therapy in triple-negative breast cancer. Cancer Research. e-Pub 2025. PMID: 40149299.
2. Hennessy MA, Gatsonis C, Jacene H, Connolly RM, Burnette BL, Stringer-Reasor EM, Romanoff J, Taurone A, Le-Petross HT, Stearns V, Lawhn-Heath C, Sepulveda KA, DeMichele AM, Mankoff DA, Wolff AC. ECOG-ACRIN EA1211: Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT Trial). Future Oncology, 2025. e-Pub 2025.
3. Shaitelman, SF, Le-Petross, H, Raso, G, Swanson, DM, Schalck, A, Contreras, A, Yang, F, Muruganandham, M, Zhao, GZ, Sawakuchi, GO, Kim, L, Batra, H, Smith, BD, Stauder, MC, Woodward, W, Reddy, JP, Litton, J, Thompson, A, Bedrosian, I, Mittendorf, EA. PRECISE. International Journal of Radiation Oncology Biology Physics 121(1):90-96, 2025. e-Pub 2025. PMID: 39147206.
4. Wang X, Zhao L, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Colfer L W, Alexander A, Vines A, Bopparaju S, Woodward W, Chu R, Zhang J, Yam C, Loo L W M, Nasrazadani A, Le-Petross H, Woodman S, Futreal A, Rare Tumor Initiative Team, Tripathy D. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. NPJ Precis Oncol, 2024. e-Pub 2024. PMID: 39558017.
5. Piotrowski MJ, Yi M, Le-Petross C, Teshome M, Kuerer HM, Lee J, Hunt KK, DeSnyder SM. Optimization of Intraoperative Lumpectomy Specimen Labeling Improves Concordance Between Surgeon and Pathology 1(1), 2024. e-Pub 2024.
6. Guirguis MS, Adrada B, Yam C, Tripathy D, Candelaria R, Yang W, Patel M, Moseley T, Perez F, Whitman GJ, Leung JWT, Le-Petross HT, Lane DL, Huo L, Litton J, Valero V, Hung KK, Arun B, Mohamed R, Sun J, Korkut A, Xu Z, Pashapoor S, White J, Son JB, Thompson A, Wei P, Ma J, Moulder S, Rauch GM. Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer. JCO. e-Pub 2024.
7. Nakhlis F, Niman SM, Ueno NT, Troll E, Ryan S, Yeh E, Warren L, Bellon J, Harrison B, Iwase T, Carisa Le-Petross HT, Saleem S, Teshome M, Whitman GJ, Woodward WA, Overmoyer B, Tolaney SM, Regan M, Lynce F, Layman RM. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer, 2023. PMID: 38155272.
8. Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang K, Korkut A, Lane DL, Le-Petross HC, T Leung JW, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, JM. Early Prediction of Response to Neoadjuvant Systemic Therapy of Triple Negative Breast Cancer using Radiomics on DCE-MRI. Front Oncol 13(eCollection 2023):1-11, 2023. e-Pub 2023.
9. Xu Z, Rauch DE, Mohamed RM, Pashapoor S, Zhou Z, Panthi B, Son JB, Hwang KP, Musall BC, Adrada BE, Candelaria RP, Leung JWT, Le-Petross HTC, Lane DL, Perez F, White J, Clayborn A, Reed B, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yang W, Yam C, Ma J. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835523.
10. Boughey JC, Rosenkranz KM, Ballman KV, McCall L, Haffty BG, Cuttino LW, Kubicky CD, Le-Petross HT, Giuliano AE, Van Zee KJ, Hunt KK, Hahn OM, Carey LA, Partridge AH. Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). J Clin Oncol 41(17):3184-3193, 2023. e-Pub 2023. PMID: 36977292.
11. Le-Petross HT, Scoggins ME, Clemens MW. Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance. J Breast Imaging 5(3):360-372, 2023. e-Pub 2023. PMID: 38416893.
12. Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HT, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GM. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel) 15(4), 2023. e-Pub 2023. PMID: 36831368.
13. Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, Ma J. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Front Oncol 13:1264259, 2023. e-Pub 2023. PMID: 37941561.
14. Breast Imaging EPO, Sanford MF, Slanetz PJ, Lewin AA, Baskies AM, Bozzuto L, Branton SA, Hayward JH, Le-Petross HT, Newell MS, Scheel JR, Sharpe RE, Ulaner GA, Weinstein SP, Moy L. Expert Panel on Breast Imaging, Sanford MF, Slanetz PJ, et al. ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update. J Am Coll Radiol. 2022;19(11S):S304-S318. doi:10.1016/j.jacr.2022.09.020. J Am Coll Radiol 11S(11S):S304-S318, 2022. e-Pub 2022. PMID: 36436958.
15. Huang ML, Hess K, Ma J, Santiago L, Scoggins ME, Arribas E, Adrada BE, Le-Petross HT, Leung JWT, Yang W, Geiser W, Candelaria RP. Prospective comparison of synthesized mammography with DBT and full-field digital mammography with DBT uncovers recall disagreements that may impact cancer detection. Acad Radiol 29(7):1039-1045, 2022. e-Pub 2022. PMID: 34538550.
16. Candelaria RP, Adrada BE, Lane DL, Rauch GM, Moulder SL, Thompson AM, Bassett RL, Arribas EM, Le-Petross HT, Leung JWT, Spak DA, Ravenberg EE, White JB, Valero V, Yang WT. Mid-treatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple-negative breast cancer. Ultrasound Med Biol 48(6):1010-1018, 2022. e-Pub 2022. PMID: 35300879.
17. Breast Imaging EPO, Le-Petross HT, Slanetz PJ, Lewin AA, Bao J, Dibble EH, Golshan M, Hayward JH, Kubicky CD, Leitch AM, Newell MS, Prifti C, Sanford MF, Scheel JR, Sharpe RE, Weinstein SP, Moy L. ACR Appropriateness Criteria® Imaging of the Axilla. J Am Coll Radiol 19(5S):S87-S113, 2022. e-Pub 2022. PMID: 35550807.
18. Cuttino LW, McCall L, Kubicky C, Ballman KV, Le-Petross HT, Hunt KK, Haffty B, Rosenkranz KM, Boughey JC. The feasibility of radiotherapy after breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) Trial. Int J Radiat Oncol Biol Phys 112(3):636-642, 2022. e-Pub 2022. PMID: 34634438.
19. Guirguis MS, Adrada BE, Scoggins ME, Moseley TW, Dryden MJ, Le-Petross HC, Rauch GM, Whitman GJ. The challenging image-guided preoperative breast localization: A modality-based approach. AJR Am J Roentgenol 218(3):423-434, 2022. e-Pub 2022. PMID: 34612680.
20. Guirguis MS, Checka C, Adrada BE, Whitman GJ, Dryden MJ, Sun J, Ding QQ, Le-Petross HT, Rauch GM, Clemens M, Moseley TW. Bracketing with multiple radioactive seeds to achieve negative margins in breast conservation surgery: Multiple seeds in breast surgery. Clin Breast Cancer 22(2):e158-e166, 2022. e-Pub 2022. PMID: 34187752.
21. Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary outcomes after multimodality therapy in breast cancer patients presenting with ipsilateral supraclavicular node involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
22. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. ASO visual abstract: Contralateral axillary metastasis in patients with inflammatory breast cancer. Ann Surg Oncol 28(Suppl 3):458-459, 2021. e-Pub 2021. PMID: 34052918.
23. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral axillary metastasis in patients with inflammatory breast cancer. Ann Surg Oncol 28(13):8610-8621, 2021. e-Pub 2021. PMID: 34125346.
24. Patel MM, Le-Petross HT. Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients. Chin Clin Oncol 10(6):56, 2021. e-Pub 2021. PMID: 34806397.
25. Kurlander DE, Le-Petross HT, Shuck JW, Butler CE, Selber JC. Robotic DIEP patient selection: Analysis of CT angiography. Plast Reconstr Surg Glob Open 9(12):e3970, 2021. e-Pub 2021. PMID: 35070606.
26. Breast Imaging EPO, Weinstein SP, Slanetz PJ, Lewin AA, Battaglia T, Chagpar AB, Dayaratna S, Dibble EH, Goel MS, Hayward JH, Kubicky CD, Le-Petross HT, Newell MS, Sanford MF, Scheel JR, Vincoff NS, Yao K, Moy L. ACR Appropriateness Criteria® supplemental breast cancer screening based on breast density. J Am Coll Radiol 18(11S):S456-S473, 2021. e-Pub 2021. PMID: 34794600.
27. Balema W, Liu D, Shen Y, El-Zein R, Debeb BG, Kai M, Overmoyer B, Miller KD, Le-Petross HT, Ueno NT, Woodward WA. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Med 10(18):6261-6272, 2021. e-Pub 2021. PMID: 34327874.
28. Musall BC, Abdelhafez AH, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Le-Petross H, Arribas E, Lane DL, Spak DA, Leung JWT, Hwang KP, Son JB, Elshafeey NA, Mahmoud HS, Wei P, Sun J, Zhang S, White JB, Ravenberg EE, Litton JK, Damodaran S, Thompson AM, Moulder SL, Yang WT, Pagel MD, Rauch GM, Ma J. Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer. J Magn Reson Imaging 54(1):251-260, 2021. e-Pub 2021. PMID: 33586845.
29. Wood ME, Liu H, Storrick E, Zahrieh D, Le-Petross HC, Jung SH, Zekan P, Kemeny MM, Charlamb JR, Wang LX, Unzeitig GW, Johnson CS, Garber JE, Marshall JR, Bedrosian I. The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial 14(7):753-762, 2021. e-Pub 2021. PMID: 33849913.
30. Chung HL, Le-Petross HT, Leung JWT. Imaging updates to breast cancer lymph node management. Radiographics 41(5):1283-1299, 2021. e-Pub 2021. PMID: 34469221.
31. Kida K, Hess KR, Lim B, Iwase T, Chainitikun S, Valero V, Lucci A, Le-Petross HT, Woodward WA, Krishnamurthy S, Hortobagyi GN, Tripathy D, Ueno NT. Validation of prognostic stage and anatomic stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer. Cancers (Basel) 12(11):3105, 2020. e-Pub 2020. PMID: 33114311.
32. Porembka JH, Ma J, Le-Petross HT. Breast density, MR imaging biomarkers, and breast cancer risk. Breast J 26(8):1535-1542, 2020. e-Pub 2020. PMID: 32654416.
33. Yalniz C, Campbell D, Le-Petross C, Shin K, Bevers TB, Hess KR, Whitman GJ. The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings. Breast J 26(7):1289-1295, 2020. e-Pub 2020. PMID: 32108973.
34. DeFazio MV, Arribas EM, Ahmad FI, Le-Petross HT, Liu J, Chu CK, Santiago L, Clemens MW. Application of three-dimensional printed vascular modeling as a perioperative guide to perforator mapping and pedicle dissection during abdominal flap harvest for breast reconstruction. J Reconstr Microsurg 36(5):325-338, 2020. e-Pub 2020. PMID: 32000277.
35. Grant SR, Krishnamurthy S, Le-Petross C, Valero V, Teshome M, Woodward WA. An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer. Breast J 26(5):1022-1024, 2020. e-Pub 2020. PMID: 31960546.
36. Ruiz-Flores L, Whitman GJ, Le-Petross HTC, Hess KR, Parikh JR. Variation in technical quality of breast MRI. Acad Radiol 27(4):468-475, 2020. e-Pub 2020. PMID: 31371208.
37. Breast Imaging EPO, Lewin AA, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, Hayward JH, Le-Petross HT, Newell MS, Rewari A, Scheel JR, Stuckey AR, Suh WW, Ulaner GA, Vincoff NS, Weinstein SP, Slanetz PJ. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. J Am Coll Radiol 11S(11S):S428-S439, 2019. e-Pub 2019. PMID: 31685110.
38. Yalniz C, Rosenblat J, Spak D, Wei W, Scoggins M, Le-Petross C, Dryden MJ, Adrada B, Dogan BE. Association of retrospective peer review and positive predictive value of magnetic resonance imaging-guided vacuum-assisted needle biopsies of breast. Eur J Breast Health 15(4):229-234, 2019. e-Pub 2019. PMID: 31620681.
39. Spak DA, Le-Petross HT. Screening modalities for women at intermediate and high risk for breast cancer. Curr Breast Cancer Rep 11(3):111-116, 2019. e-Pub 2019.
40. Eghtedari M, Le-Petross H, Babiera GV, Albarracin CT, Hess KR, Woodtichartpreecha P, Whitman GJ. Not all patients with a diagnosis of a radial scar require excision. Breast J 25(4):792-794, 2019. e-Pub 2019. PMID: 31087426.
41. Raj SD, Agrons MM, Woodtichartpreecha P, Kalambo MJ, Dogan BE, Le-Petross H, Whitman GJ. MRI-guided needle localization: Indications, tips, tricks, and review of the literature. Breast J 25(3):479-483, 2019. e-Pub 2019. PMID: 30924216.
42. Breast Imaging: EPO, Holbrook AI, Moy L, Akin EA, Baron P, Didwania AD, Heller SL, Le-Petross HT, Lewin AA, Lourenco AP, Mehta TS, Niell BL, Slanetz PJ, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria® breast pain. J Am Coll Radiol 15(11S):S276-S282, 2018. e-Pub 2018. PMID: 30392596.
43. Expert Panel on Breast Imaging: Niell BL, Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, Heller SL, Holbrook AI, Le-Petross HT, Lewin AA, Mehta TS, Slanetz PJ, Stuckey AR, Tuscano DS, Ulaner GA, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria® evaluation of the symptomatic male breast. J Am Coll Radiol 15(11S):S313-S320, 2018. e-Pub 2018. PMID: 30392600.
44. Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC. The Feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) Trial. Ann Surg Oncol 25(10):2858-2866, 2018. e-Pub 2018. PMID: 29987605.
45. Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and efficacy of panitumumab plus neoadjuvant chemotherapy in patients with primary HER2-negative inflammatory breast cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
46. Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. Surg Clin North Am 98(4):787-800, 2018. e-Pub 2018.
47. Candelaria RP, Hansakul P, Thompson AM, Le-Petross H, Valero V, Bassett R, Huang ML, Santiago L, Adrada BE. Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?. Am J Surg 17(4):30237‐4, 2018. e-Pub 2018. PMID: 28712671.
48. Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC. Axillary ultrasound identifies residual nodal disease after chemotherapy: Results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol 210(3):1-8, 2018. e-Pub 2018. PMID: 29381381.
49. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer. Clin Breast Cancer 18(1):e73-e77, 2018. e-Pub 2018. PMID: 28755879.
50. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. e-Pub 2018. PMID: 29721054.
51. Le-Petross HT, Hess KR, Knudtson JD, Lane DL, Moseley TW, Geiser WR, Whitman GJ. Effect of Mammography on Marker Clip Migration After Stereotactic-Guided Core Needle Breast Biopsy. Curr Probl Diagn Radiol 46(6):410-414, 2017. e-Pub 2017. PMID: 28390794.
52. Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. A Phase II Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 99(4):777-783, 2017. e-Pub 2017. PMID: 28843370.
53. Raghavendra A, Sinha AK, Le-Petross HT, Garg N, Hsu L, Patangan M, Bevers TB, Shen Y, Banu A, Tripathy D, Bedrosian I, Barcenas CH. Mammographic breast density is associated with the development of contralateral breast cancer. Cancer 123(11):1935-1940, 2017. e-Pub 2017. PMID: 28135395.
54. Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, Fornage B, Le-Petross C, Hoda S, McCall L, Hunt KK, investigators A. A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol 23(8):2438-45, 2016. e-Pub 2016. PMID: 27221361.
55. Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Ann Surg 263(4):802-7, 2016. e-Pub 2016. PMID: 26649589.
56. Bedrosian I, Xing Y, Abdel Rahman S, Allen L, Le-Petross H, Whitman GJ, Meric-Bernstam F, Hunt KK, Babiera GV, Cormier JN. A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Ann Surg Oncol 23(1):23-9, 2016. e-Pub 2016. PMID: 26156655.
57. Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HT. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol, 2015. e-Pub 2015. PMID: 25646192.
58. Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer. Ann Surg Oncol 11(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
59. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, in Oncology AFCT. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455-61, 2013. e-Pub 2013. PMID: 24101169.
60. Dogan BE, Le-Petross CH, Stafford JR, Atkinson N, Whitman GJ. MRI-Guided Vacuum-Assisted Breast Biopsy Performed at 3 T With a 9-Gauge Needle: Preliminary Experience. AJR Am J Roentgenol 199(5):W651-3, 2012. e-Pub 2012. PMID: 23096211.
61. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The Role for Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer. Ann Surg Oncol 19(10):3177-84, 2012. e-Pub 2012. PMID: 22772869.
62. Litton JK, Ready K, Chen H, Gutierrez-Barrera A, Etzel CJ, Meric-Bernstam F, Gonzalez-Angulo AM, Le-Petross H, Lu K, Hortobagyi GN, Arun BK. Earlier age of onset of BRCA mutation-related cancers in subsequent generations. Cancer 118(2):321-5, 2012. e-Pub 2012. PMID: 21913181.
63. Haygood TM, Arribas E, Liu QM, Atkinson EN, Brennan PC, Santiago L, Carkaci S, Lane D, Stephens TW, LePetross H, Adrada B, Davis P, Whitman GJ. Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. AJR 197(4):W761-8, 2011. e-Pub 2011. PMID: 21940549.
64. Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S, Jackson EF, Harrell RK, Reed BJ, Yang WT. MRI Features of Inflammatory Breast Cancer. AJR Am J Roentgenol 197(4):W769-76, 2011. e-Pub 2011. PMID: 21940550.
65. Le-Petross HT, Whitman GJ, Atchley DP, Yuan Y, Gutierrez-Barrera A, Hortobagyi GN, Litton JK, Arun BK. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer 117(17):3900-7, 2011. e-Pub 2011. PMID: 21365619.
66. Cohen L, Chen Z, Arun B, Shao Z, Dryden M, Xu L, Le-Petross C, Dogan B, McKenna BJ, Markman M, Babiera G. External qigong therapy for women with breast cancer prior to surgery. Integr Cancer Ther 9(4):348-53, 2010. e-Pub 2010. PMID: 21106615.
67. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HM. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116(12):2884-9, 2010. e-Pub 2010. PMID: 20564395.
68. Le-Petross H, Hylton N. Role of Breast MR imaging in Neoadjuvant Chemotherapy. Magn Reson Imaging Clin N Am 18(2):249-58, viii-ix, 2010. e-Pub 2010. PMID: 20494310.
69. Le-Petross H, Kundra V, Szklaruk J, Wei W, Hortobagyi GN, Ma J. Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging 31(4):889-94, 2010. e-Pub 2010. PMID: 20373433.
70. Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, Oh J, Litton J, Hwang RF, Mittendorf EA. Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer 10(1):52-8, 2010. e-Pub 2010. PMID: 20133259.
71. Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 50(2):231-8, 2009. e-Pub 2009. PMID: 19164229.
72. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KK. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol 191(3):646-52, 2008. e-Pub 2008. PMID: 18716089.
73. Yang WT, Lane DL, Le-Petross HT, Abruzzo LV, Macapinlac HA. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology 245(3):692-702, 2007. e-Pub 2007. PMID: 17911538.
74. Ma J, Son JB, Zhou Y, Le-Petross H, Choi H. Fast spin echo triple echo Dixon (fTED) technique for efficient T2-weighted water and fat imaging. Magn Reson Med 58(1):103-109, 2007. e-Pub 2007. PMID: 17659631.
75. Le-Petross HT. Breast MRI as a screening tool: the appropriate role. J Natl Compr Canc Netw 4(5):523-526, 2006. e-Pub 2006. PMID: 16687098.
76. Kwan AL, Boone JM, Le-Petross HT, Lindfors KK, Seibert JA. Contrast-enhanced dual-energy digital subtraction mammography: optimization of the beam energy. Proc Soc Photo Opt Instrum Eng 5745, 2005. e-Pub 2005.
77. Reddy NM, Gerscovich EO, Jain KA, Le-Petross HT, Brock JM. Vasectomy-related changes on sonographic examination of the scrotum. J Clin Ultrasound 32(8):394-398, 2004. e-Pub 2004. PMID: 15372447.
78. Le-Petross HT, Patel MD, Roberts CC, Liu PT, Karstaedt PJ. Magnetic resonance imaging estimation of breast cancer size after large core needle biopsy. Journal of Women's Imaging 16:160-165, 2004. e-Pub 2004.
79. Harnett J, Le H. Cardiovascular effects of erythropoietin. Dial Transplant 22(9), 1993. e-Pub 1993.
80. Harnett J, Le H. Importance of blood pressure control in dialysis patients receiving erythropoietin. J Am Soc Nephrol 3(3):426, 1992. e-Pub 1992.
81. Belitsky B, Ellsmere L, Le H, Sketris I. Relationship of cyclosporine clearance to demographic and outcome variables in kidney transplant patients, 1990. e-Pub 1990.
82. Schalck DA, Tran T, Li J, Sei DE, Bai MS, Hu DM, Lin MJ, Bright DS, Reddick MS, Yang DF, Batra DH, Contreras DA, Gabriela Raso DM, Stauder DM, Hoffman DK, Reddy DJ, Nead DK, Smith DB, Sawakuchi DG, Woodward W, Watowich DS, Litton DJ, Bedrosian DI, Mittendorf DE, Le-Petross DH, Shaitelman DS. The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem. Nature Genetics.
83. Navin N, Schalck A, Tran T, Li J, Sei E, Bai S, Hu M, Lin J, Bright DS, Reddick MS, Yang DF, Batra DH, Contreras DA, Gabriela Raso DM, Stauder DM, Hoffman DK, Reddy DJ, Nead DK, Smith DB, Sawakuchi DG, Woodward W, Watowich DS, Litton DJ, Bedrosian I, Mittendorf E, Le-Petross H, Shaitelman S. The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem. Nature Genetics.
84. Schalck A, Tran T, Li J, Sei E, Bai S, Hu M, Lin J, Bright SJ, Reddick S, Yang F, Batra H, Contreras A, Raso MG, Stauder MC, Hoffman KE, Reddy JP, Nead KT, Smith BD, Sawakuchi GO, Woodward WA, Watowich SS, Litton JK, Bedrosian I, Mittendorf EA, Le-Petross H, Navin N, Shaitelman SF. The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem.

Manuals, Teaching Aids, Other Teaching Publications

1. Candelaria RP, Le-Petross H. November Case of the Month. Society of Breast Imaging, 2010.
2. Le H. Students attitudes towards health care system, 1992.
3. Le H. Antiemetics. The Ottawa Valley Regional Drug Information Service Publication, 1991.

Other Articles

1. Wang X, Zhao L, Song X, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Larry W Coffer II, Alexander A, Vines A, Bopparaju S, Woodward WA, Chu R, Zhang J, Yam C, M Loo LW, Nasrazadani A, Huong L, Woodman SE, Futreal A, Initiative Team RT, Tripathy D, Ueno NT Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. Nature, 2024.

Abstracts

1. Guirguis MS, Adrada B, Patel M, Perez F, Candelaria R, Yang W, Sun J, Mohamed RM, Boge M, Le-Petross HTC, Leung J, Whitman GJ, Lane DL, Scoggins ME, Moseley T, White J, Wei P, Son JB, K-P H, Panthi B, Pagel M, Hunt KK, Thompson AM, Litton JK, Valero V, Tripathy D, Yam C, Ma J, Rauch G. DCE-MRI for early prediction of excellent response versus chemoresistance in triple negative breast cancer. SABC, 2023. e-Pub 2023.
2. Mohamed RM, Panthi B, Adrada B, Candelaria R, Guirguis MS, Yang W, Boge M, Patel M, Elshafeey N, Pashapoor S, Zhou Z, Son JB, Hwang KP, Le-Petross HT, Leung J, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley T, Perez F, White J, Chen H, Sun J, Wei P, Litton JK, Valero V, Yam C, Pagel M, Ma J, Rauch GM. A pre-operative dynamic contrast enhanced MRI-based radiomics models as predictors of treatment response after neoadjuvant systemic therapy in triple negative breast cancer patients. San Antonio Breast Cancer Symposium, 2023. e-Pub 2023.
3. Rauch GM, Candelaria RP, Guirguis MS, Boge M, Mohamed RMM, Elshafeey N, Sun J, Whitman GJ, Leung J, Le-Petross HC, Santiago L, Lane D, Scoggins M, Spak D, Patel MM, Perez F, White JB, Ravenberg E, Peng W, Tripathy D, Valero V, Litton J, Huo L, Yam C, Thompson A, Ma J, Moulder SL, Yang W, Adrada BE. Integrated model for early prediction of neoadjuvant systemic therapy response in Triple Negative Breast Cancer. San Antonio Breast Cancer Symposium. e-Pub 2022.
4. Zhou Z, Elshafeey NA, Rauch DE, Adrada BE, Candelaria RP, Guirguis MS, Yang W, Boge M, Mohamed RM, Whitman GJ, Lane DL, Le-Petross HC, Leung JWT, Santiago L, Scoggins ME, Spak DA, Patel MM, Perez F, Tripathy D, Valero V, Yam C, Moulder S, White JB, Son JB, Pagel MD, Rauch GM, Ma J. Deep learning for early prediction of neoadjuvant chemotherapy response in triple negative breast cancers. San Antonio Breast Cancer Symposium. e-Pub 2022.
5. Guirguis MS, Adrada BE, Candelaria RP, Sun J, Whitman GJ, Yang WT, Boge M, Mohamed RM, Elshafeey NA, Lane DL, Le-Petross HT, Leung JWT, Santiago L, Scoggins ME, Spak DA, Patel M, Perez F, Wei P, Tripathy D, White J, Ravenberg E, Huo L, Litton J, Arun B, Valero V, Thompson A, Moulder S, Yam C, Rauch GM. Prediction of response to neoadjuvant systemic therapy in triple negative breast cancer using baseline tumor MRI characteristics and imaging patterns of response. San Antonio Breast Cancer Symposium. e-Pub 2022.
6. Elshafeey N, Hwang KP, Adrada BE, Candelaria RP, Boge M, Mahmoud RM, Chen H, Sun J, Yang W, Kotrotsou A, Musall BC, Son JB, Whitman GJ, Leung J, Le-Petross HT, Santiago L, Lane DL, Scoggins ME, Spak DA, Guirguis MS, Patel MM, Perez F, Abdelhafez AH, White JB, Hu L, Ravenberg E, Peng W, Thompson A, Damodaran S, Tripathy D, Moulder SL, Yam C, Pagel MD, Ma J, Rauch GM. Radiomics model based on Magnetic Resonance Image Compilation (MagIC) as early predictor of pathologic complete response to neoadjuvant systemic therapy in triple-negative breast cancer. San Antonio Breast Cancer Symposium. e-Pub 2022.
7. Zhang S, Rauch GM, Adrada BE, Boge M, Mohamed RMM, Abdelhafez AH, Son JB, Sun J, Elshafeey NA, White JB, Lade DL, Leung JWT, Scoggins ME, Spak DA, Arribas E, Ravenberg E, Santiago L, Moseley TW, Whitman GJ, Le-Petross HT, Musall BC, Miyoshi M, Wang X, Willis B, Hash S, Kotrotsou A, Wei P, Hwang KP, Thompson A, Moulder SL, Candelaria RP, Yang W, Ma J, Pagel MD. Pulsed electric field exposure (PEFE) applied in breast cancer: A potential normothermic clinical cancer therapy. San Antonio Breast Cancer Symposium (Virtual), 2021. e-Pub 2021.
8. Elshafeey N, Adrada BE, Candelaria RP, Abdelhafez AH, Musall BC, Sun J, Boge M, Mohammed RMM, Mahmoud HS, Son JB, Kotrosou A, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White J, Ravenberg E, Hwang KP, Wei P, Litton JK, Huo L, Tripathy D, Valero V, Thompson AM, Moulder S, Yang WT, Pagel MD, Ma J, Rauch GM. Radiomic phenotypes from Dynamic Contrast-Enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in Triple Negative Breast Cancer (TNBC). San Antonio Breast Cancer Symposium (Virtual), 2021. e-Pub 2021.
9. Le-Petross HT, Rauch GM, Adrada BE, Boge M, Mohamed RMM, Abdelhafez AH, Son JB, Sun J, Elshafeey NA, White JB, Lane DL, Leung JWT, Scoggins ME, Spak DA, Arribas E, Ravenberg E, Santiago L, Moseley TW, Whitman GJ, Le-Petross HT, Musall BC, Miyoshi M, Wang X, Willis B, Hash S, Kotrotsou A, Wei P, Hwang KP, Thompson A, Moulder SL, Candelaria RP, Yang W, Ma J, Pagel MD. Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: a pilot study. San Antonio Breast Cancer Symposium (Virtual), 2021. e-Pub 2021.
10. Rauch GM, Adrada BE, Candelaria RP, Elshafeey N, Abedelhafez AH, Musall BC, Sun J, Boge M, Mohamed RMM, Son JB, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White JB, Ravenberg E, Hwang KP, Wei P, Huo L, Litton JK, Valero V, Tripathy D, Thompson AM, Pagel MD, Ma J, Yang WT, Moulder S. Patient-reported outcomes from the Phase III IMpassion031 trial of neoadjuvant atezolizumab+ chemotherapy in early triple-negative breast cancer. San Antonio Breast Cancer Symposium (Virtual). e-Pub 2021.
11. Rauch GM, Adrada BE, Candelaria RP, Elshafeey N, Abdelhafez AH, Musall BC, Sun J, Boge M, Mohamed RMM, Son JB, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White JB, Ravenberg E, Hwang KP, Wei P, Huo L, Litton JK, Valero V, Tripathy D, Thompson AM, Pagel MD, Ma J, Yang WT, Moulder S. Volumetric changes on longitudinal Dynamic Contrast Enhanced MR Imaging (DCE-MRI) as an early treatment response predictor to Neoadjuvant Systemic Therapy (NAST) in Triple Negative Breast Cancer (TNBC) patients. San Antonio Breast Cancer Symposium (Virtual), 2021. e-Pub 2021.
12. Piotrowski M, Yi M, Contreras A, Hunt K, Hwang R, Kuerer H, Le-Petross HC, Teshome M, Underbrink A, DeSnyder S. Optimization of Intraoperative Lumpectomy Specimen Labeling Improves Concordance Between Surgeon and Pathology. 2020 Annual Meeting Official Proceedings Volume XXI, 2020. e-Pub 2020.
13. Musall BC, Adrada BE, Abdelhafez AH, Mahmoud HS, K-P H, Son JB, Ma J, Whitman G, Le-Petross H, Moseley T, Candelaria RP, Litton J, Moulder S, Yang WT, Pagel MD, Rauch GM. Optimized tumor volumes by dynamic contrast enhanced MR imaging for assessing response to neoadjuvant chemotherapy in triple negative breast cancer. Proceedings of International Society for Magnetic Resonance in Medicine 2019, 2019. e-Pub 2019.
14. Musall B, Adrada B, Abdelhafez A, Mahmoud H, K-P H, Son JB, Santiago L, Whitman G, Le-Petross H, Moseley T, Candelaria R, Helgason T, Ravenburg E, Litton J, Moulder S, Yang W, Ma J, Pagel M, Rauch G. Quantitative ADC measurement of breast cancer with ssEPI and reduced FOV diffusion weighted imaging techniques. Proceedings of International Society for Magnetic Resonance in Medicine 2019, 2019. e-Pub 2019.
15. Willey JS, Parker CA, Lim B, Valero V, Le-Petross HT, Krishnamurthy S, Woodward WA, Lucci A, Wood AL, Sun H, Babiera GV, Song J, Shen Y, Valero V, Wang X, Ueno NT. A randomized phase II study of neoadjuvant panitumumab /carboplatin/paclitaxel (PaCT) versus carboplatin/paclitaxel (CT) followed by adriamycin and cyclophosphamide (AC) for newly diagnosed primary triple-negative inflammatory breast cancer (TNIBC). Proceedings of San Antonio Breast Cancer Symposium 2017. e-Pub 2018.
16. Raghavendra AS, Sinha AK, Tripahty D, Bedrosian I, Le-Petross HL, Barcenas CH. Association Between Mammographic Breast Density (BD) and the Development of a Second Contralateral Breast Cancer (CBC): A Nested Case-control Study. e-Pub 2016.
17. Candelaria R, Huan ML, Adrada BE, Arribas EM, Scoggins ME, Schopp J, Dryden M, Le-Petross HT, Moseley T, Whitman G, Rauch GM, Santiago L. Comparing the Performance of Full-Field Digital Mammography (FFDM), Digital Breast Tomosynthesis (DBT) and Whole Breast Ultrasound (WBUS) in the Initial Staging Evaluation of Breast Cancer: Interim Results of a Prospective Study. 101st Scientific Assembly and Annual Meeting, Radiological Society of North America, 2015. e-Pub 2015.
18. Le-Petross HT, McCall L, Hunt K, Mittendorf EA, Ahrendt G, Wilke L, Leitch M, Taback B, and Boughey JC. Role of axillary ultrasound after neoadjuvant chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis (ACOSOG Z1071). J Clin Oncol 30(15 suppl):1107, 2012. e-Pub 2012.
19. Moni J, Le-Petross H, Boughey J, Hunt K, FitzGerald T. Quality assurance review center: Role in multi-institutional breast cancer trials. Breast Cancer Symposium 2011(suppl 27). e-Pub 2011.
20. Yang WT, Le-Petross HT, Gonzalez-Angulo AM, Macapinlac H, Carkaci S, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M. Functional (PET/CT) compared to conventional (mammography [M], sonography [US], MRI) imaging: Defining novel assessment modalities for inflammatory breast cancer (IBC). Proceedings of the American Society of Clinical Oncology 25(18S):600, 2007. e-Pub 2007.
21. Chen JH, Meas S, Bassett RL, Sarli VN, Upshaw J, Le-Petross C, Valero V, Lim B, Woodward WA, Lucci A. Molecular Residual Disease Precedes Radiographic Confirmation of Recurrence in Patients with Stage III Inflammatory Breast Cancer.
22. Adrada BE, Guirguis MS, Patel MM, Perez F, Candelaria RP, Yang W, Sun J, Mohamed RM, Boge M, Le-Petross HC, Leung JWT, Whitman GJ, Lane DL, Scoggins ME, Moseley T, Musall B, White J, Zhou Z, Wei P, Son JB, Hwang KP, Panthi B, Pagel M, Huo L, Hung K, Ravenberg E, Thompson A, Litton J, Valero V, Tripathy D, Moulder S, Yam C, Ma J, Rauch GM. Development of a combined model for early prediction of pathologic complete response (pCR) in triple negative breast cancer (TNBC) undergoing neoadjuvant therapy (NAT). 108th Annual Meeting of the Radiological Society of North America.
23. Xu Z, Pashapoor S, Panthi B, Bum Son J, Hwang Pin, K, Adrada BE, Candelaria RP, Guirguis MS, Patel MM, Le-Petross HT, Leung J, Scoggins ME, Whitman G, Mohamed R, Lane DL, Moseley T, Perez F, White J, Ravenberg E, Clayborn A, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt K, Moulder S, Litton J, Valero V, Tripathy D, Yang W, Yam C, Rauch GM, Ma J. Tumor Segmentation with NnU-Net On Dynamic Contrast Enhanced MR Images of Triple Negative Breast Cancer. ISMRM and ISMRT Annual Meeting Toronto 2023.
24. Panthi B, Pashapoor S, Le-Petross HT, Adrada BE, Rosalind P. Candelaria, Mary S. Guirguis, Miral M. Patel, Rania M. Mohamed, Clinton Yam, Gaiane M Rauch, Jingfei Ma. Early Prediction of Response to Neoadjuvant Systemic Therapy of Triple Negative Breast Cancer using Radiomics on DCE-MRI. ISMRM and ISMRT ANNUAL MEETING 2023 TORONTO.
25. Rauch GM, Moseley T, Guirguis M, Whitman G, Candelaria R, Leung J, Patel M, Sun J, Le-Petross HT, Lane D, Scoggins M, Perez F, Mohamed RM, Xu Z, Pashapoor S, Son JB, Hwang KP, Chen H, Wei P, Tripathy D, Yang W, Yam C, Ma J, Adrada B. DCE-MRI Tumor Volumetric Changes Predict Response To Neoadjuvant Immunochemotherapy In Triple Negative Breast Cancer Patients. ISMRM and ISMRT Annual Meeting Singapore 2024.
26. Son JB, Le-Petross HT, Rauch DE, Xu Z, Moseley TM, Adrada BE, Ma J. 3D deep- learning image reconstruction for fast spin-echo triple-echo Dixon images acquired with flexible echo-spacing (FTED-Flex). ISMRM and ISMRT Annual Meeting Singapore 2024.
27. Mohamed RM, Son JM, Adrada BE, Moseley T, Whitman G, Candelaria R, Panthi B, Chen H, Guirguis M, Leung J, Hwang KP, Pashapoor S, Patel M, Scoggins M, Le-Petross HT, Lane D, Perez F, Wei P, Xu Z, Tripathy D, Yang W, Yam C, Ma J, Rauch GM. Radiomics and Background Parenchymal Enhancement of Fibroglandular Tissue for Predicting Treatment Response in Triple-Negative Breast Cancer. ISMRM and ISMRT Annual Meeting Singapore 2024.
28. Walker CM, Kapoor MM, Mayo RM III, Sun J, Stafford RJ, Le-Petross HT. Evaluation Of AI Based Reconstruction To Improve Image Quality Of T2w Images Of The Breast. ISMRM and ISMRT.
29. Xu, Z, Son JB, Adrada BE, Moseley TW, Candelaria RP, Guirguis MS, Patel MM, Whitman GJ, Leung JWT, Le-Petross HT, Mohamed RM, Pashapoor S, Panthi B, Lane DL, Perez F, Chen H, Sun J, Wei P, Tripathy D, Yang W, Yam C, Rauch GM, Ma J. Deep learning models for predicting responses to neoadjuvant systemic therapy in triple-negative breast cancer using pre-treatment MRI. Session: A I-Powered Analysis for Cancer Diagnosis & Prognosis. ISMRM and ISMRT Annual Meeting Singapore 2024.
30. Le-Petross HT, Ma J, Christopher WM, Sun J, Muruganandham M, Yang W, Shaitelman SF. Short Supine Breast Magnetic Resonance Imaging Access Preoperative Breast Radiotherapy Boost Targets. ISMRM & ISMRT ANNUAL MEETING 2024.
31. Le-Petross HT, Son J, Ma J, Kai M, Whitman G, Guirguis M, Patel M, Kapoor M, Sun S, Lim B, Alexander A, Valero V, Lucci A, Woodward W A. Quantitative Diffusion Weighted Imaging for Predicting Response to Neoadjuvant Therapy in Patients with Inflammatory Breast Cancer. San Antonio Breast Cancer Symposium 2024.
32. Le-Petross HT, Kai M, Marx AN, Murphy, H, Alexander A, Saleem S, Whitman G, Guirguis M, Patel M, Sun S, Lim B, Valero V, Lucci A. The Impact of a Multidisciplinary Quality Assurance Conference on the Management of Inflammatory Breast Cancer. San Antonio Breast Cancer Symposium 204.
33. Chen J, Meas S, Bassett R, Sarli V, Upshaw J, Le-Petross H, Valero V, Saleem S, Lim, B, Woodward W, Lucci A. Molecular Residual Disease Precedes Radiographic Confirmation of Recurrence in Patients with Stage III Inflammatory Breast Cancer. San Antonio Breast Cancer Symposium 2024.
34. Le-Petross HT, Son JB, Ma J, Kai M, Whitman G, Guirguis M, Patel M, Kapoor M, Sun S, Lim B, Alexander A, Valero V, Lucci A, Woodward WA. Quantitative Diffusion Weighted Imaging for Predicting Response to Neoadjuvant Therapy in Patients with Inflammatory Breast Cancer.
35. Rauch GM, Guirguis MS, Candelaria RP, Elshafeey NA, Sun J, Yang W, Boge M, Mohamed RM, Whitman GJ, Lane DL, Le-Petross HC, Leung JWT, Santiago L, Scoggins ME, Spak DA, Patel MM, Perez F, Musall B, White J, Zhou Z, Wei P, Pagel M, Ma J, Damodaran S, Huo L, Ravenberg E, Thompson A, Litton J, Valero V, Tripathy D, Yam C, Moulder S, Adrada BE. Early prediction of chemo resistance versus excellent response in triple negative breast cancer patients (TNBC) with DCE-MR. 107th Annual Meeting of the Radiological Society of North America (Virtual).
36. Van Wyhe RD, Slack R, Stauder M, LimB, Teshome M, Krishnamurthy S, Le-Petross C, Ueno NT, Woodward WA. Outcomes Among Hormone Receptor Positive Metastatic Inflammatory Breast Cancer (IBC).
37. Xu Z, Pashapoor S, Panthi B, Son JB, Hwang K, Adrada BE, Candelaria RP, Guirguis MS, Patel MM, Le-Petross H, Leung J, Scoggins ME, Whitman G, Mohamed R, Lane DL, Moseley T, Perez F, White J, Ravenberg E, Clayborn A, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt K, Moulder S, Litton J, Valero V, Tripathy D, Yang W, Yam C, Rauch GM, Ma J. Tumor segmentation with nnU-Net on dynamic contrast enhanced MR images of triple negative breast cancer.
38. Candelaria R, Hess K, Lane D, Santiago L, Moulder S, Yang WT, Thompson A, Rauch G, Huang ML, Arribas EM, Scoggins ME, Moseley TW, Le-Petross HC, Spak DA, Whitman GJ, Leung JW, Valero V, Damodaran S, Litton J, White J, Adrada BE. Predicting pathologic complete response with ultrasound tumor characteristics in triple negative breast cancer patients. 105th Scientific Assembly and Annual Meeting, Radiological Society of North America.
39. Guirguis M, Adrada B, Dryden M, Le-Petross HC, Rauch G, Checka C, Whitman G, Moseley T. The feasibility of breast conservation therapy in multifocal/multicentric breast cancer using multiple radioactive seeds: a paradigm shift. Proceedings. 105th Scientific Assembly and Annual Meeting, Radiological Society of North America.
40. Elshafeey N, Adrada BE, Candelaria RP, Abdelhafez AH, Musall BC, Sun J, Boge M, Mohamed RMM, Mahmoud HS, Son JB, Kotrosou A, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White JB, Ravenberg E, Hwang KP, Wei P, Litton JK, Huo L, Tripathy D, Valero V, Am T, Moulder S, Yang WT, Pagel MD, Ma J, Rauch GM. Contribution of tumor and immune cells to PD-L1 as a predictive biomarker in triple-negative breast cancer (TNBC): Analysis from KEYNOTE-119. San Antonio Breast Cancer Symposium (Virtual).
41. Guirguis MS, Adrada BE, Le-Petross HT, Dryden MJ, Rauch GM, Whitman GJ, Moseley T. Preoperative bracketing of multifocal breast carcinoma: a multimodality approach. Society of Breast Imaging Symposium.
42. Zhou Z, Elshafeey NA, Rauch DE, Adrada BE, Candelaria RP, Guirguis MS, Yang W, Boge M, Mohamed RM, Whitman GJ, Lane DL, Le-Petross HC, Leung JWT, Santiago L, Scoggins ME, Spak DA, Patel MM, Perez F, White J, Litton J, Valero V, Tripathy D, Yam C, Son JB, Pagel MD, Rauch GM, Ma J. Prediction of pathological complete response to neoadjuvant systemic therapy of triple negative breast cancers via deep learning. 107th Annual Meeting of the Radiological Society of North America.
43. Rauch GM, Candelaria RP, Guirguis MS, Sun J, Elshafeey NA, Yang W, Boge M, Mohamed RM, Whitman GJ, Lane DL, Le-Petross HC, Leung JWT, Santiago L, Scoggins ME, Spak DA, Patel MM, Perez F, Musall B, White J, Wei P, Zhou Z, Pagel M, Ma J, Ravenberg E, Thompson A, Huo L, Litton J, Valero V, Tripathy D, Yam C, Moulder S, Adrada BE. A composite model for pathologic complete response (pCR) prediction in Triple Negative Breast Cancer (TNBC. 107th Annual Meeting of the Radiological Society of North America (Virtual).
44. Candelaria RP, Bassett R, Boge M, Patel M, Lane DL, Adrada BE, Guirguis MS, Le-Petross HT, Leung JW, Perez F, Santiago L, Scoggins ME, Spak DA, Whitman GJ, Rauch GM, Yang WT. Immunogenic response and abnormal axillary node morphology in triple negative breast cancer (TNBC) patients. 107th Annual Meeting of the Radiological Society of North America.
45. Mohamed RM, Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yang W, Boge M, Patel MM, Elshafeey NA, Pashapoor S, Zhou Z, Son JB, Hwang KP, Le-Petross HC, Leung JWT, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley TW, Perez F, White J, Ravenberg EE, Chen H, Sun J, Wei P, Thompson A, Moulder S, Hung KK, Litton J, Valero V, Tripathy D, Yam C, Pagel MD, Ma J, Rauch GM. Multi-parametric MRI-based radiomics models for early neoadjuvant systemic treatment response prediction in triple negative breast cancer. 108th Annual Meeting of the Radiological Society of North America.
46. Candelaria RP, Huang ML, Adrada BE, Arribas EM, Scoggins ME, Yang WT, Schopp J, Dryden M, Le-Petross HT, Moseley T. Comparing the performance of full-field digital mammography (FFDM), digital breast tomosynthesis (DBT) and whole breast ultrasound (WBUS) in the initial staging evaluation of breast cancer: interim results of a prospective study. 101st Scientific Assembly and Annual Meeting, Radiological Society of North America.
47. Musall BC, Adrada BE, Abdelhafez AH, Mahnoud HS, Hwang KP, Son JB, Santiago L, Whitman G, Le-Petross HT, Moseley TW, Candelaria RP, Helgason T, Ravenburg E, Litton JK, Moulder SL, Yang W, Ma J, Pagel MD, Rauch GM. Quantitative ADC measurement of breast cancer with ssEPI and reduced POV diffusion weighted imaging techniques. International Society for Magnetic Resonance in Medicine.
48. Musall BC, Ma J, Adrada BE, Abdelhafez AH, Candelaria RP, Yang WT, Hess KR, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Leung JWT, Scoggins ME, Pagel MD, Hwang KP, Bon JB, White JB, Litton JK, Damodaran S, Lim B, Willis BJ, Mahmoud HS, Megahed A, Thompson AM, Moulder SL, Rauch GM. Quantitative tumor volumes by fast dynamic contrast enhanced (DCE) MRI predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC). 105th Scientific Assembly and Annual Meeting, Radiological Society of North America.
49. Abdelhafez AH, Adrada BE, Musall BC, Ma J, Candelaria RP, Yang WT, Hess KR, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DE, Scoggins ME, Leung JWT, Pagel MD, Hwang KP, Son JB, Litton JK, Damodaran S, Lim B, White J, Mahmoud HS, Valero V, Thompson AM, Moulder SL, Rauch GM. Tumor necrosis at baseline dynamic contrast enhanced (DCE) MRI for prediction of neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC) patients. 105th Scientific Assembly and Annual Meeting, Radiological Society of North America.
50. Adrada B, Candelaria R, Hess K, Moulder S, Santiago L, Valero V, Arribas E, Moseley T, Lane D, Scoggins M, Le-Petross HC, Spak DA, Huang ML, Litton J, Thompson A, White J, Whitman G, Leung J, Yang W, Rauch G. Precision imaging: early ultrasound evaluation (US) to identify excellent responders to neoadjuvant. 105th Scientific Assembly and Annual Meeting, Radiological Society of North America.

Book Chapters

1. Le-Petross, H, Stafford, RJ, Bedrosian, I, Garvey, PB, Woodward, W, Moulder-Thompson, SL. Breast Cancer, 476-502, 2022.
2. Le-Petross H, Lim B, Hylton N. Magnetic Resonance Imaging and Neoadjuvant Chemotherapy. In: Breast Oncology: Techniques, Indications, and Interpretation. Springer Science+Business Media, 2016.
3. Le-Petross H, Caudle A. Chapter 15: Staging of Breast Cancer. In: Breast Cancer Screening and Diagnosis. 1st Ed. Springer Science + Business Media, 301-314, 2015.
4. Le-Petross HT, Stafford RJ, Morris EA. Breast MRI. In: Advanced Therapy of Breast Disease. 3rd edition. PMPH-USA, 2012.
5. Le-Petross H, Stafford J, Bedrosian I, Garvey P, Woodward W, Moulder-Thompson S. Breast Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier Saunders, 479-508, 2012.
6. Le-Petross H, Stephens T. Current Status of Computer-Aided Detection of Breast Cancer. In: Physics of Mammographic Imaging. 1st. Taylor and Francis, 165-174, 2012.
7. Le-Petross H. Stereotactic Guided Breast Biopsy. In: Breast Surgical Oncology. 1st. McGraw-Hill, 2010.
8. Le-Petross H. Ultrasound Examination of the Breast and Fine-Needle Aspiration. In: Kuerer's Breast Surgical Oncology. 1st. McGraw-Hill COmpanies Inc, 2010.
9. Singletary SE, Middleton LA, Le-Petross HT. Chapter 85: The unknown primary presenting with axillary lymphadenopathy. In: The Breast. 4th. Saunders - Elvsevier, 1373, 2009.
10. Lindfors K, Le-Petross H. Breast Imaging. In: Fundamentals of Diagnostic Radiology. Third. Lippincott Williams and Wilkins, 565-600, 2007.
11. Lindfors K, Le-Petross HT. Chapter 20: Breast imaging. In: Fundamentals of Diagnostic Radiology. 3rd. Lippincott Williams & Wilkins, 565-600, 2006.